AzTrials
AzTrials

Acute Exacerbation of COPDNCT05563493

Effects of Chair-Based Exercise Training on Exercise Capacity in Patients With Acute Exacerbation of COPD

A study testing Treatment group, Chair-Based Exercise Training in people with Acute Exacerbation of COPD, run by Necmettin Erbakan University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Chronic obstructive pulmonary disease (COPD) is the leading cause of morbidity and mortality worldwide, a respiratory disease characterized by chronic airflow limitation that is not completely reversible. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Acute Exacerbation of COPD
What is being tested?
Treatment group, Chair-Based Exercise Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteTurkey (Türkiye)
Study dates
20 Aug 2022to 30 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients who were hospitalized due to acute exacerbation of COPD

Who cannot join

  • Patients with orthopedic or neurological problems that may interfere with assessment and education,
  • Uncooperative patients,
  • Patients with advanced heart problems such as acute coronary syndrome, stable angina pectoris, severe arrhythmias (Atrial fibrillation etc.), decompensated heart failure.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Necmettin Erbakan University Nezahat Keleşoğlu Faculty of Health Sciences

    Konya, 42090

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of the Effects of Chair-Based Exercise Training on Respiratory Functions, Exercise Capacity and Quality of Life in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is the leading cause of morbidity and mortality worldwide, a respiratory disease characterized by chronic airflow limitation that is not completely reversible.

Impaired pulmonary functions, decreased exercise capacity and quality of life and increased dyspnea perception is prevalent in patients with acute exacerbations of COPD.It was demonstrated exercise training has beneficial effects in patients with acute exacerbations of COPD.

The purpose of this study to evaluate the effects of chair-based exercise training on exercise capacity, respiratory functions, dyspnea, balance, depression anxiety and quality of life in COPD patients in acute exacerbation.

Read the detailed description

Acute exacerbations of COPD are generally defined as events in the natural course of the disease characterized by a change in the patient's initial dyspnea, cough or sputum beyond normal daily variations. The main consequences of COPD in acute exacerbation are increased mortality, deterioration in health-related quality of life, faster decline in lung function, marked reduction in physical activity and worsening of peripheral muscle weakness, which have a direct impact on patients' health. Although exacerbations are diagnosed based on respiratory symptoms, there is evidence that they have systemic consequences, including a detrimental effect on skeletal muscle function, exercise tolerance and quality of life.

Chair-based exercise training is defined as a structured and progressive exercise program applied by trainers that provides stability using a chair, which is a part of exercise training for the elderly. It is thought that it would be beneficial to study such an exercise program, since COPD patients in acute exacerbation have less mobilization during hospitalization.

In a limited number of studies, some inconsistencies were observed in the exercises of patients with acute exacerbation of COPD. Studies can therefore now focus on investigating comparisons between different intervention lengths, session durations and frequencies, and intensities of exercise training. For this reason, in our planned study, we will investigate the effects of chair-based exercise training in COPD patients in acute exacerbation. There is no study in the literature investigating the effects of chair-based exercise training in COPD patients in acute exacerbation. For this reason, our study will provide important information support to the literature.

Being tested
Treatment group, Chair-Based Exercise Training, Control group, Breathing exercise
Keywords
Chair-based exercise training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Treatment group, Chair-Based Exercise TrainingOther

    The weights of the elastic bands to be used in the exercises will be determined by the physiotherapist according to the abilities and development of the participants.

    The intensity of the exercise will be adjusted according to the dyspnea or fatigue patients feel according to the Modified Borg Scale.

    During the exercises, heart rate and oxygen saturation will be measured with a pulse oximeter, and blood pressure will be measured with a sphygmomanometer.

    Chair-based exercise training will be applied to the patients every day they are hospitalized.

  • Control group, Breathing exerciseOther

    Breathing exercise will be applied to the patients every day they are hospitalized.

Study groups in NCT05563493
Study groupRoleWhat they receive
Treatment group, Chair-Based Exercise TrainingExperimentalTreatment group will receive chair-based exercise training. Chair-based exercise training consisting of 20 different exercises will be applied in 2-3 sets with an average of 8-15 repetitions. Rest between sets will average 45-60 seconds.
Receives: Other: Treatment group, Chair-Based Exercise Training
Control group, Breathing exerciseOtherControl group will receive breathing exercises.
Receives: Other: Control group, Breathing exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional Exercise Capacity

    Functional exercise capacity will be evaluated with 6-minute walk test.

    Measured: Seven day

  2. Pulmonary Function Test

    This test was evaluated using a spirometry by which is evaluated dynamic lung functions expressed as percentages of expected values.

    Measured: Seven day

Secondary outcomes (5)
  1. Dyspnea

    The severity of dyspnea during daily living activities is evaluated using the Modified Medical Research Council (MMRC) dyspnea scale.

    Measured: Seven day

  2. One Minute Sit to Stand Test

    The number of completed sit to stand repetitions in 1 minute. Patients stand/sit from a chair as many times as they can in one minute.

    Measured: Seven day

  3. Timed Up and Go Test

    The Timed Up and Go test is evaluated dynamic balance.

    Measured: Seven day

  4. Depression and Anxiety

    Evaluated using Hospital Anxiety and Depression Scale (Turkish versions of all scales)

    Measured: Seven day

  5. Life of quality

    Saint George's Respiratory Questionnaire (SGRQ) (Turkish versions of all scales) is used to assess the quality of life of COPD patients.

    Measured: Seven day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2022
  2. Study start20 Aug 2022
  3. Primary completion31 May 2023
  4. Study completion30 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05563493
Sponsor's protocol ID
1
Status last verified
Sep 2022
First submitted
26 Sep 2022
Last updated
7 Feb 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Liao S, Wang F, Lin Q, Jian F, Li Y, Zhong Q, Huang Y, Lin Y, Wang H. Effect of sitting and lying Liuzijue exercise for pulmonary rehabilitation in acute exacerbation of chronic obstructive pulmonary disease patients with non-invasive ventilation: a randomized controlled trial. Ann Palliat Med. 2021 Sep;10(9):9914-9926. doi: 10.21037/apm-21-2157.

    PubMed 34628916
  • Knaut C, Bonfanti Mesquita C, Dourado VZ, de Godoy I, Tanni SE. Evaluation of Inflammatory Markers in Patients Undergoing a Short-Term Aerobic Exercise Program while Hospitalized due to Acute Exacerbation of COPD. Int J Inflam. 2020 Apr 28;2020:6492720. doi: 10.1155/2020/6492720. eCollection 2020.

    PubMed 32411343
  • Burtin C, Decramer M, Gosselink R, Janssens W, Troosters T. Rehabilitation and acute exacerbations. Eur Respir J. 2011 Sep;38(3):702-12. doi: 10.1183/09031936.00079111. Epub 2011 Jun 30.

    PubMed 21719481
  • Kon SS, Canavan JL, Man WD. Pulmonary rehabilitation and acute exacerbations of COPD. Expert Rev Respir Med. 2012 Nov;6(5):523-31; quiz 531. doi: 10.1586/ers.12.47.

    PubMed 23134247
  • Dundar ZP, Karatas N, Duruturk N, Vatansev H, Zamani̇ A. Effects of chair-based exercise training on pulmonary function, exercise capacity, and quality of life in patients with acute exacerbation of COPD: A randomised controlled trial. Physiotherapy. 2026 Sep 16;134:102386. doi: 10.1016/j.physio.2026.102386. Online ahead of print.

    PubMed 42976662

Questions about this trial

What is this clinical trial studying?

A study testing Treatment group, Chair-Based Exercise Training in people with Acute Exacerbation of COPD, run by Necmettin Erbakan University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional Exercise Capacity (time frame: Seven day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05563493, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in